Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Evolocumab in Patients With Critical Limb Ischemia

NCT04306471 is registered in ClinicalTrials.gov with Leonardo Clavijo as lead sponsor.

NCT NCT04306471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04306471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Evolocumab in Patients With Critical Limb Ischemia
Lead sponsor
Leonardo Clavijo
Phase
Phase 4
Overall status
Unknown status
Start date
February 24, 2020
Completion date
February 4, 2022
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia